Skip to main content
Nature Communications logoLink to Nature Communications
. 2017 Nov 29;8:16165. doi: 10.1038/ncomms16165

Corrigendum: Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state

Iebe Rossey, Morgan S A Gilman, Stephanie C Kabeche, Koen Sedeyn, Daniel Wrapp, Masaru Kanekiyo, Man Chen, Vicente Mas, Jan Spitaels, José A Melero, Barney S Graham, Bert Schepens, Jason S McLellan, Xavier Saelens
PMCID: PMC5717039  PMID: 29184149

Nature Communications 8: Article number: 14158; DOI: 10.1038/ncomms14158 (2017); Published February 13 2017; Updated November 29 2017.

In this Article, the clinical isolate MAD/GM3_10/14 of respiratory syncytial virus (RSV) is incorrectly described as an RSV A isolate. MAD/GM3_10/14 has been identified as an RSV B isolate on the basis of its fusion protein sequence. The fusion protein sequences of the clinical isolates used in this study have been deposited in GenBank under accession codes MF361899 (MAD/GM2_2/12), MF361900 (MAD/GM2_12/12), MF361901 (MAD/GM2_13/12), MF361902 (MAD/GM2_14/12), MF361903 (MAD/GM3_10/14), MF361904 (MON/9/92), and MF361905 (MAD/GM3_7/13).


Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES